🔓Relationships Between Motives for Cannabis and Cannabidiol Use in People Who Co-Use: Results From the European Web Survey on Drugs
@FortinDavide, Vincent Leroy, Patrizia Carrieri, João Matias, Tangui Barré
https://t.co/AUrgVJoB9c
@SESSTIM@EUDrugsAgency
@annesouyris https://t.co/LYC7rr9OS0
En effet, au-delà du fentanyl, d'autres opioïdes synthétiques sont en train de remplacer l'héroïne sur les marchés européens. Cependant, ce rapport propose plusieurs pistes pour éviter une crise aux conséquences catastrophiques.
✨Préparons l’avenir !✨
💊 Au plus tard au 1er janvier 2025, de premiers médicaments à base de cannabis prendront place dans l’arsenal thérapeutique en France.
🏛️ Les Assises du cannabis médical rassembleront médecins, https://t.co/Zdl4NrtFVL.s, associations, entreprises mais avant tout patient.e.s afin d’échanger sur les enjeux sanitaires et économiques en vue d’une progressive généralisation.
Inscription sur : https://t.co/NE7jPoGIjI
ISSDP has been attending the United Nations #CND67 High Level Meeting & running an exhibit of drug policy books. Pictured @AlejandraCN86, Davide Fortin & @DrCaitlinHughes. If you attend CND this week please say hi. For a full list of texts:
https://t.co/sq1OdTqLYo
Latest paper from the #GCCRC published in the #IJDP - "Are Cannabis Use Problems Comparable Across Individuals Using for Recreational and Medical Purposes?" Led by @sznitmans. Free access for 50 days: https://t.co/tIeP5FP9xv
My first publication on #NAFLD consists in a global research priority agenda for advancing public health responses. Along with @JVLazarus and other co-authors, we selected 28 research priorities to better tackle the disease!
It was a privilege to meet with the #London Drugs Commission and provide evidence on drugs policy, #cannabis#legalisation and its consequences together with Peter Reuter, Jonathan Caulkins & @FortinDavide. LDC was set up by @MayorofLondon to consider options for drug policy laws
EU law: After 2 EU countries will have legalized #cannabis, they will not be in a position to prevent licit trade between these two countries (particularly if they share a common border). https://t.co/BOnjrcJlMU
🌱@lecese présentera les conclusions de la commission temporaire "#cannabis : sortir du stat quo, vers une légalisation encadrée" le mardi 24 janvier 2023 à 14h30. Inscription [email protected] avant le 20/01, diffusion sur https://t.co/5opTaLUFqs
https://t.co/zODPcSIlEh
Le cannabidiol ou CBD est désormais légal en France. Une enquête permet de mieux cerner les divers profils de ses consommateurs, et leurs motivations. https://t.co/jaswq1iH6F
This week we held the 15th Annual International Society for the Study of Drug Policy Conference in Lisbon. It was such a treat to see everyone and to discuss and debate the latest #DrugPolicy issues & scholarship.
🌍🤗🌎🤗🌍
#ISSDP2022
WHY PATIENT-REPORTED OUTCOMES would improve the integration of #cannabis in the health system? Excited to share my latest article for
@FrontiersIn Public Health.
https://t.co/9GaFQ7HUA7
2nd Global Workshop on Advancing the Field of #Cannabis through Standardization, October 20-22. As we emerge from a global state of prohibition, the need for harmonized international standards that assure quality and safety of cannabis becomes more urgent. https://t.co/MwV6z9VjOn